[go: up one dir, main page]

EA200601874A1 - Жидкий состав гормона роста - Google Patents

Жидкий состав гормона роста

Info

Publication number
EA200601874A1
EA200601874A1 EA200601874A EA200601874A EA200601874A1 EA 200601874 A1 EA200601874 A1 EA 200601874A1 EA 200601874 A EA200601874 A EA 200601874A EA 200601874 A EA200601874 A EA 200601874A EA 200601874 A1 EA200601874 A1 EA 200601874A1
Authority
EA
Eurasian Patent Office
Prior art keywords
growth hormone
metal salt
liquid composition
alkaline earth
earth metal
Prior art date
Application number
EA200601874A
Other languages
English (en)
Other versions
EA010626B1 (ru
Inventor
Тьюдор Арвинт
Карин Люэ Клебер
Original Assignee
Арес Трейдинг С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Арес Трейдинг С.А. filed Critical Арес Трейдинг С.А.
Publication of EA200601874A1 publication Critical patent/EA200601874A1/ru
Publication of EA010626B1 publication Critical patent/EA010626B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Настоящее изобретение относится к жидкому составу, содержащему гормон роста или вещество, которое стимулирует высвобождение или потенцирует активность эндогенного hGH; полипропилен-полиэтилен гликоля; цитрат/буфер фосфата, соль щелочного металла и соль щелочно-земельного металла или соль псевдощелочно-земельного металла, и к способу его получения.
EA200601874A 2004-04-07 2005-03-30 Жидкий состав гормона роста EA010626B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04101444 2004-04-07
PCT/EP2005/051448 WO2005105148A2 (en) 2004-04-07 2005-03-30 Liquid growth hormone formulation

Publications (2)

Publication Number Publication Date
EA200601874A1 true EA200601874A1 (ru) 2007-02-27
EA010626B1 EA010626B1 (ru) 2008-10-30

Family

ID=34928942

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601874A EA010626B1 (ru) 2004-04-07 2005-03-30 Жидкий состав гормона роста

Country Status (23)

Country Link
US (1) US7662393B2 (ru)
EP (1) EP1740213B9 (ru)
JP (1) JP4991522B2 (ru)
KR (1) KR101120879B1 (ru)
CN (1) CN100574801C (ru)
AT (1) ATE547121T1 (ru)
AU (1) AU2005237775B2 (ru)
BR (1) BRPI0508798A (ru)
CA (1) CA2559918A1 (ru)
CY (1) CY1113834T1 (ru)
DK (1) DK1740213T3 (ru)
EA (1) EA010626B1 (ru)
ES (1) ES2383994T3 (ru)
HR (1) HRP20120235T1 (ru)
IL (1) IL178416A (ru)
MX (1) MXPA06011029A (ru)
NO (1) NO337249B1 (ru)
PL (1) PL1740213T3 (ru)
PT (1) PT1740213E (ru)
RS (1) RS52310B (ru)
SI (1) SI1740213T1 (ru)
UA (1) UA89781C2 (ru)
WO (1) WO2005105148A2 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1174457B1 (en) * 1999-12-03 2004-12-22 Toray Industries, Inc. Biaxially stretched polyester film for forming
JP2010523501A (ja) * 2007-04-04 2010-07-15 セラテクノロジーズ インコーポレイティド Ｇｈｒｈ分子の医薬製剤
CA2787895A1 (en) 2010-01-22 2011-07-28 Novo Nordisk Health Care Ag Stable growth hormone compounds
MX345736B (es) 2010-01-22 2017-02-14 Novo Nordisk Healthcare Ag Hormonas de crecimiento con eficacia in vivo prolongada.
EP2417982A1 (en) * 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
EP2736490A1 (en) * 2011-07-25 2014-06-04 Sandoz AG Aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein
US8871713B2 (en) * 2013-03-01 2014-10-28 Theratechnologies Inc. Formulations of growth hormone releasing factor (GRF) molecules with improved stability
ES2841123T3 (es) 2013-04-05 2021-07-07 Formulacion Del Compuesto De La Hormona De Crecimiento Formulación del compuesto de la hormona de crecimiento
WO2017159540A1 (ja) * 2016-03-14 2017-09-21 Ｊｃｒファーマ株式会社 血清アルブミン－２０ｋ成長ホルモン融合タンパク質
CN111432880A (zh) * 2017-08-08 2020-07-17 瑞士杰特贝林生物制品有限公司 血色素结合蛋白制剂
JP2020002130A (ja) * 2018-06-25 2020-01-09 Ｊｃｒファーマ株式会社 蛋白質含有水性液剤
WO2024026224A1 (en) 2022-07-29 2024-02-01 University Of Rochester Methods for improving muscle mass, strength, or function with a combination of testosterone and growth hormone

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3325223A1 (de) * 1983-07-13 1985-01-24 Hoechst Ag, 6230 Frankfurt Gegen denaturierung bestaendige, waessrige proteinloesungen, verfahren zu ihrer herstellung und ihre verwendung
JPS60123426A (ja) * 1983-12-07 1985-07-02 Eisai Co Ltd 経鼻投与用セクレチン製剤
JPH0720861B2 (ja) * 1984-04-09 1995-03-08 ザ デュポン マーク ファーマソウテイカル カンパニー 心臓障害の処置または予防用の医薬組成物および方法
JPS6270319A (ja) * 1985-07-30 1987-03-31 インタ−ナシヨナル・ミネラルズ・アンド・ケミカル・コ−ポレイシヨン 成長促進ホルモンの安定化
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
HUT67319A (en) * 1991-08-30 1995-03-28 Life Medical Sciences Inc Compositions for treating wounds
SE9201073D0 (sv) * 1992-04-03 1992-04-03 Kabi Pharmacia Ab Protein formulation
ES2286868T3 (es) 1992-07-31 2007-12-01 Genentech, Inc. Composicion acuosa a base de hormana del crecimiento humana.
JPH0892125A (ja) * 1994-09-21 1996-04-09 Nippon Chem Res Kk 水性医薬組成物
AUPN801296A0 (en) * 1996-02-12 1996-03-07 Csl Limited Stabilised growth hormone formulation and method of preparation thereof
US20020077461A1 (en) * 1996-04-24 2002-06-20 Soren Bjorn Pharmaceutical formulation
US6759393B1 (en) * 1999-04-12 2004-07-06 Pfizer Inc. Growth hormone and growth hormone releasing hormone compositions
JP2003504346A (ja) * 1999-07-12 2003-02-04 グランデイス・バイオテツク・ゲー・エム・ベー・ハー 成長ホルモン製剤
EP1309312A2 (en) * 2000-08-07 2003-05-14 Inhale Therapeutic Systems, Inc. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
WO2003041685A1 (en) * 2001-11-14 2003-05-22 Alza Corporation Injectable depot composition
AU2003250915A1 (en) * 2002-07-09 2004-01-23 Sandoz Ag LIQUID FORMULATIONS WITH HIGH CONCENTRATION OF HUMAN GROWTH HORMONE (hgh) COMPRISING 1,2-PROLPYLENE GLYCOL
JP4949828B2 (ja) * 2003-03-18 2012-06-13 アレス トレーディング ソシエテ アノニム 溶液中での成長ホルモンの安定化

Also Published As

Publication number Publication date
JP4991522B2 (ja) 2012-08-01
HRP20120235T1 (hr) 2012-04-30
CN1946427A (zh) 2007-04-11
MXPA06011029A (es) 2007-01-25
WO2005105148A2 (en) 2005-11-10
US7662393B2 (en) 2010-02-16
PL1740213T3 (pl) 2012-08-31
HK1098708A1 (zh) 2007-07-27
WO2005105148A3 (en) 2006-07-20
NO337249B1 (no) 2016-02-22
ATE547121T1 (de) 2012-03-15
CY1113834T1 (el) 2016-07-27
CA2559918A1 (en) 2005-11-10
WO2005105148A8 (en) 2005-12-08
IL178416A (en) 2012-12-31
RS52310B (sr) 2012-12-31
ES2383994T3 (es) 2012-06-28
EP1740213B9 (en) 2012-06-13
AU2005237775A1 (en) 2005-11-10
IL178416A0 (en) 2007-02-11
KR101120879B1 (ko) 2012-02-27
DK1740213T3 (da) 2012-04-10
UA89781C2 (ru) 2010-03-10
PT1740213E (pt) 2012-03-21
CN100574801C (zh) 2009-12-30
BRPI0508798A (pt) 2007-09-04
NO20065097L (no) 2007-01-02
EA010626B1 (ru) 2008-10-30
AU2005237775B2 (en) 2010-03-04
KR20070005628A (ko) 2007-01-10
EP1740213A2 (en) 2007-01-10
US20080038292A1 (en) 2008-02-14
EP1740213B1 (en) 2012-02-29
SI1740213T1 (sl) 2012-04-30
JP2007532515A (ja) 2007-11-15

Similar Documents

Publication Publication Date Title
CY1113834T1 (el) Υγρο παρασκευασμα αυξητικης ορμονης
EA015464B9 (ru) Гербицидные составы с улучшенной эффективностью
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
WO2008057802A3 (en) Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
TR200801337T1 (tr) Suda zayıf çözülebilen farmasötik ajanlar ve antimikrobiyal ajanlar içeren kompozisyonlar.
GEP20125628B (en) Pharmaceutical compositions containing antagonist anti-cd40 antibody
TR200002812T2 (tr) Efervesan formülasyonları.
CL2004000782A1 (es) Composicion farmaceutica parenteral que comprende (a) piperacilina, (b) tazobactamo, y un acido aminocarboxilico quelante, que ademas puede contener un tampon, como citrato, y opcionalmente un aminoglicosido; procedimientos para su preparacion; y uso
ZA202407615B (en) Formulations of dengue virus vaccine compositions
TW200735897A (en) HFSH aqueous formulation
RU2011122629A (ru) Водная композиция, содержащая фолликулостимулирующий гормон
GEP20084340B (en) Pharmaceutical compositions comprising fentanyl for intranasal delivery
MY146947A (en) Antiparasitic agent for fish and method of controlling proliferation of fish parasites
NZ768547A (en) Solid formulation of insecticidal mixtures
WO2008102349A3 (en) Terbinafine formulation for iontophoresis
AR097840A1 (es) Una formulación de un conjugado de la hormona de crecimiento humana de la actividad prolongada, procedimiento, kit
ZA202204982B (en) Stable formulation of integrin antibody
CY1105167T1 (el) Συνθεσεις πepιεχουσες ενα κοσμετολογικα ενepγο οργανικο οξυ και ενα προϊον οσπριου
WO2004082707A3 (en) Stabilisation of growth hormones in solution
MX2007013327A (es) Formulaciones de liberacion prolongada.
TW200744993A (en) Crystalline forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid
MX2011011120A (es) Sales de acido isetionico que contienen nitrogeno en mezclas de tanque y de rocio listas para utilizarse en campo.
MY157943A (en) Aqueous suspension concentrates
DK1254944T3 (da) Törre sammensætninger, der indeholder hydrofob aminosyre
TW200738141A (en) Aqueous suspension concentrates

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU